Latest Takeda Pharmaceutical Company Stories
RnRMarketResearch.com adds “Osteoporosis & Osteoarthritis – Pipeline Review, H2 2014” to its store.
The Philadelphia jury awarded the man $2 million: Actos was deemed a contributing factor to the man’s bladder cancer, Takeda was found to have not warned physicians concerning the drug’s cancer
Pegasus Legal Funding LLC Can Provide Financial Assistance to Those Adversely Affected NEW YORK, Oct.
The Actos Lawsuit Purports Takeda Pharmceuticals Knew Long-Term Use Of The Medication Could Potentially Lead To Bladder Cancer. Columbus, OH (PRWEB) October
Expresses Continued Confidence in ACTOS DEERFIELD, Ill., Oct. 3, 2014 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc.
Case Funding Firm adds to funding amounts as Bellwether trials kick into high gear after $9Bil verdict is failed to be dismissed on Takeda post-trial motion. HOUSTON, Sept.
Actos Lawsuit Help Center Website reports that Takeda and Eli Lilly loses bid to have Judge throw out recent $9Bil Jury verdict. NEW ORLEANS, Sept.
Primary Research Provides Key Insights and Tools for Health Care Professionals DEERFIELD, Ill. and ALEXANDRIA, Va., Sept.
Drug makers Takeda and Eli Lilly lost a bid to have the Actos trial thrown out.